Effects of Preoperative Respiratory Physical Therapy on Postoperative Respiratory Function After Bariatric Surgery

February 4, 2016 updated by: Julio Llorens, Fundación para la Investigación del Hospital Clínico de Valencia

Effects of Preoperative Respiratory Physical Therapy on Postoperative Respiratory Function in Morbidly Obese Patients Undergoing Bariatric Surgery. A Randomized, Controlled, Clinical Trial

Background. Morbidly obese patients show an increased risk of hypoxemia and a higher incidence of postoperative pulmonary complications during the postoperative period resulting in prolonged hospital length of stay when compared with normal weight subjects. Preoperative respiratory physiotherapy including inspiratory muscle training (IMT) has been shown to reduce the incidence of post operative respiratory complications in some different settings.

Objective. To determine wether a program of preoperative respiratory physical therapy could reduce the incidence and severity of postoperative hypoxemia in morbidly obese patients undergoing laparoscopic bariatric surgery.

Setting. Hospital Clínico Universitario, Valencia, Spain.

Design and Patients. A double-blind, randomized clinical trial. 50 patients (BMI≥40%) consecutively scheduled for laparoscopic bariatric surgery were included of whom 44 completed the study. Sample size was calculated using the repeated measures of the PaO2/FiO2 ratio along the postoperative period as the primary endpoint and considering an effect size of 0.25.

Interventions. Patients were randomly assigned to receive either preoperative respiratory physical therapy (n=23) or usual care (n=21) during a month just before the date of surgery. Both groups received the same postoperative physical therapy.

Measures. Data on oxygenation (primary outcome, PaO2/Fio2 ratio) were obtained at 1hour and at 12 hours after surgery. Data on spirometry and maximum static respiratory pressures (secondary outcomes) were obtained before and after the training period, and in the postoperative period.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Background. Morbidly obese patients show an increased risk of hypoxemia during the postoperative period resulting in a higher incidence of postoperative pulmonary complications and prolonged hospital length of stay when compared with normal weight subjects. Mechanisms involved in this predisposition of morbidly obese patients for develop this physiopathologic scheme include a greater impairment on the respiratory mechanics induced by general anesthesia and paralysis -greater reduction in pulmonary and chest compliances and higher airway resistance- and an increment in ventilatory requirements. That leads to an increased work of breathing (WOB) and oxygen consumption (VO2). These effects are exaggerated in patients undergoing laparoscopic surgery because the direct effects of the pneumoperitoneum on the pulmonary mechanics. In addition, in morbidly obese patients respiratory muscles show a reduction in both strength and endurance probably a cause of the fatty tissular infiltration and the exacerbated inflammatory response usually observed in these patients.

Respiratory physical therapy has shown to be effective and reduce postoperative pulmonary complications both, as postoperative treatment and when given preoperatively. When applied postoperatively respiratory physiotherapy has proved to be able to expand pulmonary volumes and to improve arterial oxygenation, leading to decreases in postoperative pulmonary complications, specially after abdominal surgery. In the specific setting of morbidly obese patients submitted to bariatric surgery, postoperative inspiratory muscle training (IMT ) improves inspiratory muscle strength and endurance allowing an earlier recovery of pulmonary airflows.

There are scanty data about the results of applying respiratory physiotherapy on the preoperative period. However it has proved to be able to reduce the postoperative incidence of postoperative pulmonary complications in some different settings: (1) In patients after thoracic surgery, (2) In patients undergoing CABG surgery, specially in those considered at high risk for pulmonary complications and (3) after upper abdominal surgery.

At our knowledge no studies aimed to determine wether preoperative respiratory physiotherapy could improve the postoperative respiratory function in morbidly obese patients have been published.

The objective of this study was to evaluate the effects of a preoperative respiratory physical therapy program on the postoperative respiratory function in morbidly obese patients undergoing bariatric laparoscopic surgery.

Fifty morbid obese patients (BMI≥40%) consecutively scheduled for laparoscopic bariatric surgery were considered eligible. All subjects were treated by the same surgical team and were submitted to the same anesthetic procedures. All the patients were informed about the objectives and interventions of the study and signed an informed consent form. The protocol was approved by the local Human Research Ethics Committee.

The sample size was calculated using the repeated measures of the PaO2/FiO2 ratio in the postoperative period as the primary endpoint. Assuming that an increment of 25% or more in this parameter (effect size of 0.25) would be of clinical importance, with an alfa error probability of 0.05 and a power of 0.95, a required sample size of 44 patients was obtained. To account for attrition a proportion of 15% was added, reaching a total sample size of 50 patients. The calculation was carried out by means of the GPower 3.1.5 application for statistics. After inclusion, the informed consent procedure, and evaluation of baseline characteristics, the study patients were randomly and blindly divided into two groups: control group (CG) and intervention group (RPT). Randomization was done with a computer generated randomization table and individual closed sealed envelopes. An investigator blinded to the allocation sequence picked consecutive allocation envelopes for consecutive participants.

Surgery was scheduled on the day 32 to 36 from the baseline day for all patients. Anesthetic management was standardized. Patients received no premedication. In the operating room patients were placed in reverse trendelemburg (RTDL) position (30º). Continuous positive airway pressure (CPAP) at 10 cmH2O was applied to all patients during the administration of oxygen in air (FiO2 0.8) for 5 minutes. After preoxygenation anesthesia was induced with propofol, 3 mg.kg-1 based on ideal body weight (IBW= X + 0.91* height (cm) - 152,4-1; X = 50 for men; X= 45 for women) and fentanyl 0,1 microg.kg-1, followed by rocuronium 0.6 mg. kg-1. Then all the patients were ventilated using pressure support ventilation (PSV) with a inspiratory pressure of 10 cmH2O, PEEP 10 cmH2O and a minimum respiratory rate of 10 breaths.min-1 (Ventilator Engström CS, GE Healthcare, Finland). When neuromuscular blockade was complete tracheal intubation was performed maintaining the RTDL position at 30º. The radial artery was cannulated for continuous monitoring of arterial blood pressure and arterial blood gas measurements. Anesthesia was maintained by continuous infusion of propofol and remifentanil to target a bispectral index ™ (XP version 3.0, Aspect Medical Inc. Norwood, MA) between 40 and 50. Neuromuscular blockade was maintained with rocuronium and continuously monitored (TOF Watch, Bluestar Enterprises, Inc., Chanhassen, MN). Remifentanil was discontinued at the time of the removal of the laparoscope. Residual neuromuscular blockade was reversed with neostigmine, 0.05 mg/kg IV (IBW). Normothermia was maintained intraoperatively using a forced warm air system (Bair Hugger®, Arizant Healthcare Inc., Eden Prairie, MN, USA).

Intraoperative mechanical ventilation was the same for both groups of patients. The lungs were ventilated with volume controlled ventilation (VCV) with a mixture of 50% oxygen in air, and a tidal volume of 6 mL.kg-1 (IBW), inspiratory to expiratory ratio 1:2, and PEEP 10 cmH2O. Respiratory rate was adjusted to maintain end-tidal carbon dioxide partial pressure (etCO2) between 30 and 35 mmHg. An alveolar recruitment strategy (ARS) was applied after the onset of pneumoperitoneum. ARS was performed by increasing PEEP in increments of 5 cmH2O from 0 to 20 cmH2O using pressure controlled ventilation with a driving pressure similar to the airways plateau pressure obtained during VCV. Once PEEP reached 20 cmH2O the driving pressure was augmented to reach 45 cmH2O. After 10 breaths at maximal airways pressure, PEEP was decreased in steps of 2 cmH2O and static compliance of the respiratory system was measured at each step in order to determine the lung's closing pressure. Then a second ARS was applied and PEEP was set at 2 cm H2O higher than the closing pressure. At the end of surgery a new ARS was applied, before the extubation. In this case PEEP after the ARS was kept in 10 cmH2O until the extubation.

Tracheal extubation was performed in the RTDL position (30º). Fully monitored patients were then transferred to the PACU in a semi-sitting position, while receiving a high flow of oxygen in air at a FiO2 of 0.5.

Postoperative analgesia in the first 12 h was intravenous paracetamol (1 g every 6 h) and intravenous dexketoprofen (50 mg every 8 h) for all patients.

In order to know the training effects we recorded the patient follow-up to the physical therapy program and measured forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), maximal inspiratory pressure (PiMAX), and maximal expiratory pressure (PeMAX) (Datospir-600D, SIBEL SA Spain) before and at the end of the 30 days of training. All the patients were also instructed and trained about these measurements, aiming to avoid any learning effect during the study. The measurements were performed with the patients on a sitting position and wearing a nasal clip. PiMAX was measured from residual volume and PeMAX from total lung capacity. Five maneuvers were performed for each patient, and the three most acceptable were registered. The highest value obtained was considered for calculations.

Spirometry was performed according to American Thoracic Society (ATS) recommendations, employing the above mentioned spirometer (Datospir-600D) previously calibrated . Three acceptable curves and two replicable ones were considered, allowing a maximum of eight attempts to each patient. The choices of the best values were done according to ATS criteria . The obtained values were expressed as percentage of normal values calculated according to Knudson et al.

All the functional data were obtained by the same investigator, namely, the physical therapist.

Study Type

Interventional

Enrollment (Actual)

44

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Spain
      • Valencia, Spain, 46021
        • Hospital Clínico Universitario de Valencia

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

- Adult morbidly obese patients (BMI>40%) consecutively scheduled for bariatric surgery

Exclusion Criteria:

  • Age > 65 years
  • Pregnancy
  • Severe psychiatric disorders
  • Disability to perform a valid spirometry and/or correctly use IMT and incentive spirometer devices
  • Bronchial asthma requiring regular therapy
  • Smoking less than two months before surgery
  • Chronic obstructive pulmonary disease
  • Restrictive lung disease or lung surgery
  • Cardiac disease associated with dyspnoea > NYHA II

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Respiratory Physical Therapy
Patients assigned to interventional group (Respiratory Physical Therapy) were undergone a program of inspiratory muscular training (IMT) and incentive spirometer for a period of 30 days before the actual date of surgery. PiMAX, PeMAX and spirometry parameters were measured at the randomization day (baseline values)
Procedure: Respiratory Physical Therapy
Patients were randomly assigned to receive either a preoperative respiratory physiotherapy program (Intervention group, RPT) which included lung re-expansion (Incentive Spirometer, Voldyne5000, Teleflex medical USA) and respiratory muscle training (Threshold IMT, Respironics Inc. Pittsburgh, PA, USA) or usual care (Control group). Immediately after randomization the RPT group patients received detailed instructions about the training program and how correctly use the IMT and incentive spirometer devices. The patients trained daily, for 30 consecutive days. Each session consisted in 20 minutes of IMT and incentive spirometer. The patients adherence to the program was evaluated weekly by the physical therapist. Postoperative physical therapy was the same for both groups and consisted in lung re-expansion exercise with the aid of the incentive spirometer. Besides, patients were placed in sitting position rather than lying and early mobilization was stimulated.
Other Names:
  • Inspiratory muscle training
  • Incentive spirometer
No Intervention: Control
Usual care for the four weeks before surgery. PiMAX, PeMAX and spirometry parameters were measured at the randomization day (baseline values).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Intergroup difference in Arterial Oxygen partial pressure / Inspired Oxygen Fraction ratio (PaO2/FiO2)
Time Frame: Two Time Points: At one and at twelve hours after the patients's arrival to the post-anesthesia care unit
Two Time Points: At one and at twelve hours after the patients's arrival to the post-anesthesia care unit

Secondary Outcome Measures

Outcome Measure
Time Frame
Intragroup and intergroup differences in Maximal Inspiratory Pressure (MIP)
Time Frame: Two Time Points: At the end of the physiotherapy program and at twelve hours after the arrival to the PACU,compared with the baseline values.
Two Time Points: At the end of the physiotherapy program and at twelve hours after the arrival to the PACU,compared with the baseline values.
Intergroup difference in Arterial carbon dioxide (PaCO2)
Time Frame: Two Time Points: At one and at twelve hours after the patients's arrival to the post-anesthesia care unit
Two Time Points: At one and at twelve hours after the patients's arrival to the post-anesthesia care unit

Other Outcome Measures

Outcome Measure
Time Frame
Intragroup and intergroup spirometry values (FVC and FEV1) in the postoperative period
Time Frame: Two Time Points: At one and at twelve hours after the patients's arrival to the PACU
Two Time Points: At one and at twelve hours after the patients's arrival to the PACU

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Fundación para la Investigación del Hospital Clínico de Valencia

Investigators

  • Study Director: Julio Llorens, MD, PhD, Hospital Clínico Universitario de Valencia. Spain.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2011

Primary Completion (Actual)

March 1, 2012

Study Completion (Actual)

March 1, 2012

Study Registration Dates

First Submitted

April 7, 2013

First Submitted That Met QC Criteria

April 8, 2013

First Posted (Estimate)

April 10, 2013

Study Record Updates

Last Update Posted (Estimate)

February 8, 2016

Last Update Submitted That Met QC Criteria

February 4, 2016

Last Verified

April 1, 2013

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • EC-08-2011

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Morbid Obesity

Clinical Trials on Respiratory Physical Therapy

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Africa

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe